Mettler Toledo (MTD): financials, SEC filings and peers
Mettler Toledo (MTD) is a life sciences tools & services company in the Health Care sector of the S&P 500, headquartered in Columbus, Ohio.
It was founded in 1945 and joined the S&P 500 on September 6, 2016.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Laboratory Analytical Instruments”.
Mettler Toledo at a glance
- Revenue (12 months)
- $4.2B
- Revenue growth
- +6.5%
- Operating margin
- 28.5%
- Net income (12 months)
- $934M
- Free cash flow (12 months)
- $871M
- Cash
- $52M
- Debt
- $2.0B
- Diluted EPS (12 months)
- $46.10
Twelve months to September 30, 2026, from the 10-Q filed November 6, 2026.
Latest twelve months
Over the twelve months to September 30, 2026, Mettler Toledo reported revenue of $4.2 billion, about the same as a year earlier (+6.5%).
Its operating margin was 28.5%: for every $100 of sales, about $28 was left as operating profit.
Net income was $934 million (22.2% of revenue), 11.8% higher than a year earlier.
Operating cash flow was $984 million and capital spending $114 million, leaving free cash flow of $871 million (20.7% of revenue).
At the end of the period it held $52 million in cash and $2.0 billion in debt, a net debt position of $1.9 billion.
The diluted share count fell 2.7% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $3.1 billion in fiscal 2020 to $4.0 billion in fiscal 2025, about 5.5% a year.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.7B | $3.9B | $3.8B | $3.9B | $4.0B |
| Revenue growth | 20.5% | 5.4% | -3.4% | 2.2% | 4.0% |
| Operating margin | — | — | — | — | — |
| Net income | $769M | $873M | $789M | $863M | $869M |
| Free cash flow | $801M | $738M | $861M | $864M | $849M |
| Diluted EPS | $32.78 | $38.41 | $35.90 | $40.48 | $42.05 |
Fiscal years as reported in Mettler Toledo’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed November 6, 2026 — quarterly report
- 8-K filed November 5, 2026 — Earnings results
- 8-K filed August 3, 2026 — Executive or director change; Regulation FD disclosure
- 10-Q filed July 31, 2026 — quarterly report
- 8-K filed July 30, 2026 — Earnings results
- 8-K filed May 13, 2026 — Executive or director change
- 8-K filed May 11, 2026 — Shareholder vote results
- 10-Q filed May 8, 2026 — quarterly report
Companies like Mettler Toledo
Other S&P 500 companies in Life Sciences Tools & Services:
- AAgilent TechnologiesSanta Clara, California
- CRLCharles River LaboratoriesWilmington, Massachusetts
- DHRDanaher CorporationWashington, D.C.
- ILMNIllumina, Inc.San Diego, California
- IQVIQVIADurham, North Carolina
- TECHBio-TechneMinneapolis, Minnesota
- TMOThermo Fisher ScientificWaltham, Massachusetts
- WATWaters CorporationMilford, Massachusetts
More from Health Care
Questions about Mettler Toledo
Is Mettler Toledo's revenue growing?
Yes. Revenue for the twelve months to September 30, 2026 was $4.2 billion, up 6.5% from a year earlier, according to its SEC filings.
Is Mettler Toledo profitable?
Yes. It earned $934 million in net income over the twelve months to September 30, 2026, a net margin of 22.2%.
Does Mettler Toledo have more cash or more debt?
At September 30, 2026 it had $52 million in cash and $2.0 billion in debt, so more debt than cash.
When did Mettler Toledo last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on November 6, 2026.
Which companies are similar to Mettler Toledo?
In the S&P 500, Mettler Toledo is grouped in Life Sciences Tools & Services within the Health Care sector. Agilent Technologies (A), Charles River Laboratories (CRL), Danaher Corporation (DHR), Illumina, Inc. (ILMN), IQVIA (IQV) are in the same group.
Understand the numbers
Source: Mettler Toledo’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.